Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v6-EN | Version v1-EN | |
---|---|---|
Language | English | English |
Date Updated | 2018-12-10 | 2018-11-29 |
Drug Identification Number | 01926691 | 01926691 |
Brand name | CALCIMAR SOLUTION INJ 200UNIT/ML | CALCIMAR SOLUTION INJ 200UNIT/ML |
Common or Proper name | Calcimar | Calcimar |
Company Name | SANOFI-AVENTIS CANADA INC | SANOFI-AVENTIS CANADA INC |
Ingredients | CALCITONIN | CALCITONIN |
Strength(s) | 200UNIT | 200UNIT |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAMUSCULAR SUBCUTANEOUS | INTRAMUSCULAR SUBCUTANEOUS |
Packaging size | Vial multidose, 200 U / mL | Vial multidose, 200 U / mL |
ATC code | H05BA | H05BA |
ATC description | ANTI-PARATHYROID HORMONES | ANTI-PARATHYROID HORMONES |
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | 2018-12-17 | 2018-12-17 |
Actual start date | ||
Estimated end date | 2019-01-18 | 2019-01-11 |
Actual end date | ||
Shortage status | Anticipated shortage | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | Delay in production | Delay in production |
Health Canada comments |